(주)세포바이오

NEWS ROOM

NEWS ROOM
- ABOUT
- R&D
- PIPELINE
- PRODUCT
- NEWS ROOM
- CONTACT
NEWS ROOM

Press release

Press release

CEFObio Co., Ltd., Amicogen, and Beyond-Cell signed the business agreement for the commercialization of cell therapy agents.

2023.10.23

|

Views 1948

File

news_img03.jpg

CEFObio Co., Ltd., Amicogen, and Beyond-Cell signed the business agreement for the commercialization of cell therapy agents.

PREV
There are no previous article.

NEXT CEFObio Co., Ltd. signed the supply contract with Synercar for STeMiN cosmetics raw materials at the “2023 First Half Boom Up Korea Export Consultation” held at COEX on April 12 (Wed).